Beskrivning
| Land | Norge |
|---|---|
| Lista | OAX Equities |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
2025-06-11 23:55:15
NOT FOR DISTRIBUTION, PUBLICATION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR
INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, JAPAN, HONG KONG, SOUTH AFRICA OR THE
UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION, PUBLICATION
OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF
ANY OF THE SECURITIES DESCRIBED HEREIN.
Oslo, 11 June 2025
Reference is made to the stock exchange announcement by Observe Medical ASA
("Observe Medical" or the "Company", OSE ticker: OBSVR) earlier today, regarding
the placement of a conditional private placement (the "Private Placement"),
where it was also stated that the board of directors intends to carry out a
subsequent offering (the "Subsequent Offering") directed towards existing
shareholders of the Company as of 11 June 2025 (as registered in the VPS two
trading days thereafter) who (i) were not included in the wall-crossing phase of
the Private Placement, (ii) were not allocated shares in the Private Placement,
and (iii) are not resident in a jurisdiction where such offering would be
unlawful, or would (in jurisdictions other than Norway) require any prospectus,
filing, registration or similar action. Completion of the Subsequent Offering
will be subject to (i) approval from the Company's extraordinary general
meeting, (ii) completion of the Private Placement and (iii) the publication of a
prospectus by the Company that is approved by the Financial Supervisory
Authority of Norway.
Date on which the terms and conditions of the repair issue were announced: 11
June 2025
Last day including right: 11 June 2025
Ex-date: 12 June 2025
Record date: 13 June 2025
Date of approval: on or about 3 July 2025 (date of extraordinary general meeting
expected to authorise the Company's board of directors to issue shares in the
Subsequent Offering)
Maximum number of new shares: 24,000,000
Subscription price: NOK 0.50
For further information, please contact:
Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com
Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com
This information is published in accordance with the requirements of the
Continuing Obligations.